Chinese Journal of Pharmacovigilance ›› 2021, Vol. 18 ›› Issue (2): 196-198.
DOI: 10.19803/j.1672-8629.2021.02.21

Previous Articles     Next Articles

Cace Analysis of General Numbness and Dyspnea Caused by Foscarnet Sodium for Injection

LIU Yang, MA Chunhua, LIANG Lianchun*   

  1. Department of General Infection, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China
  • Received:2020-01-06 Revised:2021-02-26 Online:2021-02-15 Published:2021-02-26

Abstract: Objective To explore the mechanism of foscarnet sodium causing general numbness and dyspnea and to analyze the related literature. Methods A case of liver failure with cytomegalovirus infection was diagnosed and treated in our hospital. The symptoms of numbness and dyspnea occurred during the application of foscarnet sodium. Through literature analysis, the mechanism of the occurrence of foscarnet sodium related adverse reactions was discussed. Results Foscarnet sodium could cause general numbness and dyspnea, which might be related to hypocalcemia. Conclusion During the application of foscarnet sodium, the patients should be closely monitored, and adverse reactions should be found and treated in time.

Key words: foscarnet sodium, numbness, adverse drug reaction

CLC Number: